| 1 |
33563204 | Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways. | 2022 |
1 |
| 2 |
35595877 | Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor. | 2022 May 21 |
1 |
| 3 |
34748820 | NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis. | 2021 Dec |
1 |
| 4 |
32301059 | Ticagrelor reverses the mitochondrial dysfunction through preventing accumulated autophagosomes-dependent apoptosis and ER stress in insulin-resistant H9c2 myocytes. | 2020 Jun |
1 |
| 5 |
32832010 | Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades. | 2020 |
1 |
| 6 |
30721704 | Effects of ticagrelor on the sodium/calcium exchanger 1 (NCX1) in cardiac derived H9c2 cells. | 2019 May 5 |
1 |
| 7 |
29367102 | Effects of prasugrel on membrane potential and contractile activity of rat ventricular myocytes. | 2018 Feb |
1 |
| 8 |
29992382 | Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. | 2018 Jul 10 |
1 |
| 9 |
24643079 | Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. | 2014 Jun |
2 |
| 10 |
22546677 | Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents. | 2012 Jun 1 |
1 |
| 11 |
22071958 | Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor. | 2011 Dec |
2 |
| 12 |
19846210 | The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats. | 2010 Mar |
1 |